Suppr超能文献

膀胱内灌注卡介苗、丝裂霉素-C和噻替派预防术后膀胱肿瘤复发

[Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].

作者信息

Wang S H

机构信息

Beijing Hospital.

出版信息

Zhonghua Wai Ke Za Zhi. 1992 Jul;30(7):410-2, 443-4.

PMID:1301342
Abstract

We observed the effects of intravesical irrigation with BCG (group B), Mitomycin-C (group M), and Thiotepa (group T) in prophylaxis of bladder tumor recurrence after surgical treatment. Follow-up for 1-10 years showed that the recurrence rate of bladder tumor was 12.5% (3/24) in group B, 46.9% (15/33) in group M, and 61.8% (21/34) in group T respectively. The effect of BCG was far better than that Mitomycin-C and Thiotepa (P < 0.01). In 5 cases, who failed to Thiotepa, also showed satisfactory results after use of intravesical BCG. Considering the side-effects of intravesical BCG, Thiotepa or Mitomycin-C should be used as the first choice of drugs in preventing the tumor recurrence.

摘要

我们观察了膀胱内灌注卡介苗(B组)、丝裂霉素C(M组)和噻替派(T组)对手术治疗后膀胱肿瘤复发的预防作用。1至10年的随访显示,B组膀胱肿瘤复发率为12.5%(3/24),M组为46.9%(15/33),T组为61.8%(21/34)。卡介苗的效果远优于丝裂霉素C和噻替派(P<0.01)。5例对噻替派治疗无效的患者,使用膀胱内卡介苗后也取得了满意的效果。考虑到膀胱内卡介苗的副作用,噻替派或丝裂霉素C应作为预防肿瘤复发的首选药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验